Meloxicam Effect on Leukocyte Migration under Shear Stress: A New Perfused Triple Chamber (Hofbauer Chamber) Assay Simulating an in Vitro Vascular Wall
Restricted accessResearch articleFirst published online January, 1999
Meloxicam Effect on Leukocyte Migration under Shear Stress: A New Perfused Triple Chamber (Hofbauer Chamber) Assay Simulating an in Vitro Vascular Wall
Leukocyte migration plays a tremendous role during inflammation. Different drugs are able to influence migration of leukocytes. Several authors have attempted to establish methods for investigation of leukocyte migration. Migration of leukocytes under conditions simulating natural blood flow and shear stress is poorly understood. Moreover, leukocyte migration in the simultaneous presence of endothelial cells and smooth muscle cells (SMC) has not yet been examined thoroughly. The aim of the current study was to create a new three-dimensional assay investigating migration during simulated perfusion. The assay was used for investigating the effect of meloxicam on leukocyte migration under shear stress.
Methods
Different concentrations of meloxicam (0.09, 0.9, and 9.0 ng/mL) were used in a newly developed triple migration chamber system for investigation of leukocyte migration (n=7). This new system allows inclusion of SMC- layers. Assay precision tests were done using intra-assay (within-day variability) and interassay (day-to-day variability) controls.
Results
Intra-assay and interassay controls showed reliable results (coefficient of variation: intra-assay 8.53%; interassay 11.39%). Meloxicam in a clinically relevant concentration of 0.9 ng/mL was able to reduce the migration of leukocytes under shear stress (71 ± 14% SD; P<0.05), whereas higher and lower concentrations showed a dose dependent effect.
Conclusion
This new perfusion system allows investigation of drugs, such as meloxicam, on leukocyte migration under shear stress. Moreover, this assay may be used for studies on other cell-cell interactions, as well as on drug influences.
Get full access to this article
View all access options for this article.
References
1.
IssekutzAC, ChuluyanHE, LopesN.CD11/CD18-independent transendothelial migration of human polymorphonuclear leukocytes and monocytes: involvement of distinct and unique mechanism. J Leukoc Biol1995;57:553–61.
2.
ZimmermanGA, PrescottSM, McIntyreTM.Endothelial cell interactions with granulocytes: tethering and signaling molecules. Immunol Today1992;14:93–100.
3.
MackayCR, ImhofBA.Cell adhesion in the immune system. Immunol Today1993;14:111–4.
4.
ButcherEC.Leukocyte-endothelial cell recognition: Three (or more) steps to specificity and diversity. Cell1991;67:1033–9.
OzkaragozF, RudloffHB, RajaramanS, MushtahaAA, SchmalstiegFC, GoldmanAS.The motility of human milk macrophages in collagen gels. Pediatr Res1988;23:449–52.
10.
RochaB, HastonWS, FreitasAA.Lymphocyte migration into collagen gels: role of lymph. Scand J Immunol1984;19:297–305.
11.
IslamLN, McKayIC, WilkinsonPC.The use of collagen or fibrin gels for the assay of human neutrophil chemotaxis. J Immunol Methods1985;85:137–51.
12.
TaylorRF, PriceTH, SchwartzSM, DaleDC.Neutrophil-endothelial cell interactions on endothelial monolayers grown on micropore filters. J Clin Invest1981;67:584–7.
13.
ShasbyDM, LindSE, ShasbySS, GoldsmithJC, HunninghakeGW.Reversible oxidant-induced increases in albumin transfer across cultured endothelium: alterations in cell shape and calcium homeostasis. Blood1985;65:605–14.
14.
HakkertBC, KuijpersTW, LeeuwenbergJF, van MourikJA, RoosD.Neutrophil and monocyte adherence to and migration across monolayers of cytokine-activated endothelial cells: the contribution of CD18, ELAM-1, and VLA-4. Blood1991;78:2721–6.
15.
DarbyH, BrownKA, AndersonRA, WilliamsBT, DumondeDC.Transendothelial chemotaxis in-vitro of human monocytes. J Immunol Methods1988;113:157–63.
16.
NavabM, HoughGP, StevensonLW, DrinkwaterDC, LaksH, FogelmanAM.Monocyte migration into the subendothelial space of a coculture of adult human aortic endothelial and smooth muscle cells. J Clin Invest1988;82:1853–63.
17.
MigliorisiG, FolkesE, PawlowskiN, CramerEB.In-vitro studies of human monocyte migration across endothelium in response to leukotriene B4 and f-Met-Leu-Phe. Am J Pathol1987;127:157–67.
18.
Sunder-PlassmannG, HofbauerR, SengoelgeG, HorlWH.Quantification of leukocyte migration: improvement of a method. Immunol Invest1996;25:49–63.
19.
HofbauerR, SpeiserW and KapiotisS.Ibuprofen inhibits migration of human leukocytes through endothelial cell monolayers. Life Sci1998;62:1775–81.
20.
HofbauerR, MoserD, HammerschmidtV, KapiotisS, FrassM.Ketamine reduces significantly the migration of leukocytes through endothelial cell monolayers. Crit Care Med1998;26:1545–9.
21.
BaghesthanianM, HofbauerR, KressHG, WojtaJ, FabryA, BinderBR, KaunC, MuellerMR, MehrabiMR, KapiotisS, SengoelgeG, GhannadanM, LechnerK, ValentP.Thrombin augments vascular cell-dependent migration of human mast cells: Role of MGF. Thromb Haemost1997;77:577–84.
22.
SillaberC, BaghestanianM, HofbauerR, VirgoliniI, BanklHC, FürederW, AgisH, WillheimM, LeimerM, ScheinerO, BinderBR, KienerHP, BevecD, FritschG, MajdicO, KressHG, GadnerH, LechnerK, ValentP.Molecular and functional characterization of the urokinase receptor on human mast cells. J Biol Chem1997;272:7824–32.
23.
BaghesthanianM, HofbauerR, KienerHP, BanklHC, WimazalF, WillheimM, ScheinerO, FurederW, MuellerMR, LechnerK, ValentP.The c-kit ligand stem cell factor and anti-IgE promote expression of monocyte chemoattractant protein-1 in human lung mast cells. Blood1997;90:4438–49.
24.
IssekutzAC, IssekutzTB.Quantitation and kinetics of polymorphonuclear leukocyte and lymphocyte accumulation in joints during adjuvant arthritis in the rat. Lab Invest1991;64:656–63.
25.
WalterUM, IssekutzAC.The role of E- and P-selectin in neutrophil and monocyte migration in adjuvant-induced arthritis in the rat. Eur J Immunol1997;27:1498–505.
26.
PatelJ, ChonmaitreeT, SchmalstiegF.Effect of modulation of polymorphonuclear leukocyte migration with anti-CD18 antibody on pathogenesis of experimental otitis media in guinea pigs. Infect Immun1993;61:1132–5.
27.
WeinbergCB, BellEA.Blood vessel model constructed from collagen and cultured vascular cells. Science1986;231:397–400.
28.
StichtenothDO, WagnerB, FroehlichJC.Effects of meloxicam and indomethacin on cyclooxygenase pathways in healthy volunteers. J Investig Med1997;45:44–9.
29.
KapiotisS, BesemerJ, BevecD, ValentP, BettelheimP, LechnerK, SpeiserW.Interleukin-4 counteracts pyrogen-induced downregulation of thrombomodulin in cultured human vascular endothelial cells. Blood1991;78:410–5.
30.
JaffeEA, NachmanRL, BeckerCG, MinickCR.Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest1973;52:2745–56.
31.
DecherchiP, CochardP, GauthierP.Dual staining assessment of Schwann cell viability within whole peripheral nerves using calcein-AM and ethidium homodimer. J Neurosci Methods1997;71:205–13.
32.
ChristG, SeiffertD, HufnaglP, GesslA, WojtaJ, BinderB.Type 1 plasminogen activator inhibitor of endothelial cells is downregulated by smooth muscle cells. Blood1993;81:1277–83.
33.
KirschenlohrHL, MetcalfeJC, WeissbergPL, GraingerDJ.Proliferation of human aortic vascular smooth muscle cells in culture is modulated by active TGFB. Cardiovasc Res1995;29:848–55.
34.
GreenwayAL, HertzogPJ, DevenishRJ, LinnaneAW.Constitutive and virus-induced interferon production by peripheral blood leukocytes. Exp Hematol1995;23:229–35.
35.
Van AgtmaelMA, ButterJJ, ProtierEJG, van BoxtelCJ.Validation of an improved reversed-phase high-performance liquid chromatography assay with reductive electrochemical detection for the determination of artemisinin derivatives in man. Ther Drug Monit1998;20:109–16.
36.
LansmanJB, HallamTJ, RinkTJ.Single stretch-activated ion channel in vascular endothelial cells as mechanotransducers?Nature1987;325:811–3.
SchwarzG, CallewaertG, DroogmansG, NilusB.Shear stress induced calcium transients in endothelial cells from human umbilical cord veins. J Physiol (Lond)1992;458:527–38.
39.
BuschU, HeinzelG, NarjesH, NehmizG, TurckD, KrimmerJ, RoschW.Pharmacokinetics of meloxicam in patients with hepatic cirrhosis in comparison with healthy volunteers. Clin Drug Invest1996;11:97–107.
40.
BhagyalakshmiA, BerthiaumeF, ReichKM, FrangosJA.Fluid shear stress stimulates membrane phospholipid metabolism in cultured human endothelial cells. J Vasc Res1992;29:443–9.
41.
NollertMU, EskinSG, McIntireLV.Shear stress increases inositol triphosphate levels in human endothelial cells. Biochem Biophys Res Commun1990;170:281–7.
DaviesPF, RobetewskyjA, GriemML.Quantitative studies of endothelial cell adhesion: directional remodeling of focal adhesion sites in response to flow forces. J Clin Invest1994;93:2031–8.
44.
IshidaT, PetersonTE, KovachNL, BerkBC.MAP kinase activation by flow in endothelial cells: role of B1 integrins and tyrosine kinases. Circ Res1996;79:310–6.
45.
PhelpsP, StanislawD.Polymorphonuclear leukocyte motility in vitro. I. Effect of pH, temperature, ethyl alcohol, and caffeine, using a modified Boyden chamber technic. Arthritis Rheum1969;12:181–8.
46.
SchorSL.Cell proliferation and migration on collagen substrata in vitro. J Cell Sci1980;41:159–75.
